SCHEMBL6644124

SCHEMBL6644124

NC(=O)CCC[CH]CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1043398 0.86
SCHEMBL10354272 0.86 CNR1 (0.46)
SCHEMBL15774854 0.79 CNR1 (0.42)
SCHEMBL6387092 0.79
SCHEMBL6068913 0.77
SCHEMBL6467649 0.76 FAAH (0.58)
SCHEMBL6069030 0.75 CNR1 (0.53)
SCHEMBL6030467 0.75 CNR1 (0.59)
SCHEMBL435772 0.72
SCHEMBL6391712 0.72 LMNA (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897939-B1 BENZOIMIDAZOLE-CARBOXYLIC ACID AMIDE DERIVATIVES FOR TREATING METABOLIC OR CARDIOVASCULAR DISEASES SANOFI SA (FR) 2017-02-01 EP disclosed
US-9156796-B2 Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators SANOFI (FR) 2015-10-13 US disclosed
EP-1395554-A1 SUBSTITUTED CARBAZOLES AS INHIBITORS OF SPLA2 ELI LILLY AND COMPANY (US) 2004-03-10 EP disclosed
WO-2002079154-A1 SUBSTITUTED CARBAZOLES AS INHIBITORS OF SPLA2 ELI LILLY AND COMPANY (US) 2002-10-10 WO disclosed